Samira Eynali

Samira Eynali

Auto-generated profile, based on publicly available information

Samira Eynali

Radiation biology research center, Iran University of medical sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
ANAli Neshastehriz
Ali Neshastehriz
MTMousa Tabei
Mousa Tabei
SMShayan Maleki
Shayan Maleki
SESamira Eynali
Samira Eynali
ASAli Shakeri-Zadeh
Ali Shakeri-Zadeh

23 October 2016 in International Journal of Hyperthermia
Verified
Journal Article
Closed access
SESamira Eynali
Samira Eynali
SKSamideh Khoei
Samideh Khoei
SKSepideh Khoee
Sepideh Khoee
EEElaheh Esmaelbeygi
Elaheh Esmaelbeygi
The purpose of this study was to evaluate the combined effects of heat and polylactic-co-glycolic acid (PLGA) nanoparticles, as 5-fluorouracil carriers with/without iron oxide core, on the viability and proliferation capacity of human colon cancer cell line HT-29 in the spheroid model. HT-29 spheroid cells were treated with different concentrations of 5-FU or 5-FU-loaded into both nanoparticles for 74 h. Hyperthermia was then performed at 43 °C for 60 min. Finally, the effects of the mentioned treatments on cell viability and proliferation capacity were evaluated using the trypan blue dye exclusion test and colony formation assay, respectively. Our results showed that hyperthermia, in combination with 5-FU or PLGA nanoparticles as 5-FU carriers, significantly enhanced the cytotoxic effects as compared to the control group. Considering that nanoparticles could increase the intracellular concentration of drugs in cancer cells, the extent of cytotoxic effects following treatment with 5-FU-loaded into both nanoparticles was significantly higher than that with free 5-FU. In addition, the presence of iron oxide cores in nanoparticles during hyperthermia enhanced the cytotoxic effects of hyperthermia compared with nanoparticles without iron oxide core. Based on this study, hyperthermia in combination with 5-FU-loaded PLGA nanoparticles with iron oxide core drastically reduced the proliferation capacity of HT-29 cells; therefore, it may be considered as a new direction in the treatment of colon cancer.

11 May 2015 in International Journal of Hyperthermia
Verified
Journal Article
Closed access
EEElaheh Esmaelbeygi
Elaheh Esmaelbeygi
SKSamideh Khoei
Samideh Khoei
SKSepideh Khoee
Sepideh Khoee
SESamira Eynali
Samira Eynali
In this study the effect of PLGA polymeric nanoparticles as a 5-fluorouracil (5-FU) carrier with and without iron oxide core and hyperthermia were investigated on the level of DNA damage in a spheroid culture model of HT-29 colon cancer cell lines by alkaline comet assay. First, HT-29 colon cancer cells were cultured in vitro as spheroids with a mean diameter of 100 µm. The spheroids were then treated with different concentrations of 5-FU or nanoparticles as 5-FU carriers with and without an iron oxide core for one volume-doubling time of the spheroids (71 h) and hyperthermia at 43 °C for 1 h. Finally, the effect of treatment on viability and level of DNA damage was examined using trypan blue dye exclusion assay and alkaline comet assay, respectively. Results showed that hyperthermia in combination with 5-FU or nanoparticles as 5-FU carriers significantly induced the most DNA damage as compared with the control group. The extent of DNA damage following treatment with 5-FU-loaded nanoparticles combined with hyperthermia was significantly more than for 5-FU combined with hyperthermia. In comparison to the effect of 5-FU-loaded nanoparticles with the iron oxide core and 5-FU-loaded nanoparticle without the iron oxide core, the nanoparticles with the iron oxide core combined with hyperthermia induced more DNA damage than the nanoparticles without the iron oxide core. According to this study, hyperthermia is a harmful agent and nanoparticles are effective delivery vehicles for drugs into colon cancer cells. The iron oxide filled nanoparticles increased the effect of the hyperthermia. All these factors have a significant role in the treatment of colorectal cancer cells.

5 October 2016 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
MMMehdi Mousavi
Mehdi Mousavi
HNHassan Ali Nedaei
Hassan Ali Nedaei
SKSamideh Khoei
Samideh Khoei
SESamira Eynali
Samira Eynali
KKKarim Khoshgard
Karim Khoshgard
RRRasoul Iraji Rad
Rasoul Iraji Rad
Purpose: Gold nanoparticles (GNP) have significant potential as radiosensitizer agents due to their distinctive properties. Several studies have shown that the surface modification of nanoparticles with methyl polyethylene glycol (mPEG) can increase their biocompatibility. However, the present study investigated the radiosensitization effects of mPEG-coated GNP (mPEG-GNP) in B16F10 murine melanoma cells under irradiation of 6 MeV Electron beam. Materials and methods: The synthesized GNP were characterized by UV-Visible spectroscopy, dynamic light scattering, transmission electron microscopy, and zeta potential. Enhancement of radiosensitization was evaluated by the clonogenic assay at different radiation doses of megavoltage electron beams. Results: It was observed that mPEG-GNP with a hydrodynamic size of approximately 50 nm are almost spherical and cellular uptake occurred at all concentrations. Both proliferation efficiency and survival fraction decreased with increasing mPEG-GNP concentration. Furthermore, significant GNP sensitization occurred with a maximum dose enhancement factor of 1.22 at a concentration of 30 μM. Conclusions: Pegylated-GNP are taken up by B16F10 cancer cells and cause radiosensitization in the presence of 6 MeV electrons. The radiosensitization effects of GNP may probably be due to biological processes. Therefore, the underlying biological mechanisms beyond the physical dose enhancement need to be further clarified.

1 October 2019 in Physica E: Low-dimensional Systems and Nanostructures
Verified
Journal Article
Closed access
NJNaser Jafarzadeh
Naser Jafarzadeh
MNMarzieh Nadafan
Marzieh Nadafan
RMRasoul Malekfar
Rasoul Malekfar
ASAli Shakeri-Zadeh
Ali Shakeri-Zadeh
AMAlireza Meidanchi
Alireza Meidanchi
SESamira Eynali
Samira Eynali

1 September 2017 in Iranian Biomedical Journal
Verified
Journal Article
Open access
PDF file
KMKave Moloudi
Kave Moloudi
ANAli Neshasteriz
Ali Neshasteriz
AHArshad Hosseini
Arshad Hosseini
NENazila Eyvazzadeh
Nazila Eyvazzadeh
MSMehdi Shomali
Mehdi Shomali
AAAsaad Azarnezhad
Asaad Azarnezhad
The Iranian Biomedical Journal (ISSN 1028-852X) is an international quarterly publication of the Pasteur Institute of Iran.